Very rapid early weight loss (first 12 weeks) is usually fluid loss from osmotic diuresis, not fat
A medically supervised infusion that replenishes iron levels directly, bypassing the digestive system for faster, more effective results
4Use the Interactive Syringe for a visual reference of the resulting volume
Retatrutide produced substantial reductions in liver fat up to 82.4% at 24 weeks with higher doses in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), as well as significant reductions in the urine albumin-to-creatinine ratio (UACR) compared to placebo in post-hoc analyses, suggesting a potential renal-protective effect
The variability in trial durations, ranging from 3 to 12 weeks across the included studies, and differences in the number of titration steps for each drug may further influence the reported incidence of gastrointestinal adverse events, particularly for agents like tirzepatide, where nausea risk escalates with higher doses (e.g., OR = 4.36, 95% CI: 3.425.61 at 10 mg) (Liu et al., 2025)
The approval of Wegovy in the U.S
